IFN-ε mediates TNF-α-induced STAT1 phosphorylation and induction of retinoic acid-inducible gene-I in human cervical cancer cells

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4542-4549

  Matsumiya, Tomoh ^a   Prescott, Stephen M ^a   Stafforini, Diana M ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON EPSILON; MESSENGER RNA; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; INTERFERON EPSILON, HUMAN; INTERFERON RECEPTOR; INTERFERON-EPSILON, HUMAN; STAT1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CANCER; CLASSIFICATION; DRUG EFFECT; FEMALE; GENETICS; HELA CELL; METABOLISM; PHOSPHORYLATION; PROMOTER REGION; UTERINE CERVIX TUMOR;

DEAD-BOX RNA HELICASES; FEMALE; HELA CELLS; HUMANS; INTERFERONS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RECEPTORS, INTERFERON; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 59649113110     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4542     Document Type: Article

References (48)

1. Hiscott, J. 2004. Another detour on the Toll road to the interferon antiviral response. Nat. Struct. Mol. Biol. 11: 1028-1030.
2. Matikainen, S., J. Siren, J. Tissari, V. Veckman, J. Pirhonen, M. Severa, Q. Sun, R. Lin, S. Meri, G. Uze, et al. 2006. Tumor necrosis factor α enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J. Virol. 80: 3515-3522.
3. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413: 732-738.
4. Hardy, M. P., C. M. Owczarek, L. S. Jermiin, M. Ejdeback, and P. J. Hertzog. 2004. Characterization of the type I interferon locus and identification of novel genes. Genomics 84: 331-345.
5. Hu, R., J. Bekisz, H. Schmeisser, P. McPhie, and K. Zoon. 2001. Human IFN-α protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity. J. Immunol. 167: 1482-1489.
6. Ikeda, H., K. Chamoto, T. Tsuji, Y. Suzuki, D. Wakita, T. Takeshima, and T. Nishimura. 2004. The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci. 95: 697-703.
7. Hovnanian, A., D. Rebouillat, M. G. Mattei, E. R. Levy, I. Marie, A. P. Monaco, and A. G. Hovanessian. 1998. The human 2′,5′-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. Genomics 52: 267-277.
8. Diebold, S. S., M. Montoya, H. Unger, L. Alexopoulou, P. Roy, L. E. Haswell, A. Al-Shamkhani, R. Flavell, P. Borrow, and C. Reis e Sousa. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424: 324-328.
9. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737.
10. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
11. Kovarik, P., D. Stoiber, P. A. Eyers, R. Menghini, A. Neininger, M. Gaestel, P. Cohen, and T. Decker. 1999. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway. Proc. Natl. Acad. Sci. USA 96: 13956-13961.
12. Sen, G. C., and S. N. Sarkar. 2005. Hitching RIG to action. Nat. Immunol. 6: 1074-1076.
13. Yoneyama, M., M. Kikuchi, K. Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, E. Foy, Y. M. Loo, M. Gale, Jr., S. Akira, et al. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175: 2851-2858.
14. Loo, Y. M., D. M. Owen, K. Li, A. K. Erickson, C. L. Johnson, P. M. Fish, D. S. Carney, T. Wang, H. Ishida, M. Yoneyama, et al. 2006. Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 103: 6001-6006.
15. Quayle, A. J. 2002. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J. Reprod. Immunol. 57: 61-79.
16. Ware, C. F. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 23: 787-819.
17. Saito, T., R. Hirai, Y. M. Loo, D. Owen, C. L. Johnson, S. C. Sinha, S. Akira, T. Fujita, and M. Gale, Jr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. USA 104: 582-587.
18. Jackson, A. L., S. R. Bartz, J. Schelter, S. V. Kobayashi, J. Burchard, M. Mao, B. Li, G. Cavet, and P. S. Linsley. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21: 635-637.
19. Bridge, A. J., S. Pebernard, A. Ducraux, A. L. Nicoulaz, and R. Iggo. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34: 263-264.
20. Roberts, R. M., L. Liu, Q. Guo, D. Leaman, and J. Bixby. 1998. The evolution of the type I interferons. J. Interferon Cytokine Res. 18: 805-816.
21. Imaizumi, T., N. Yagihashi, M. Hatakeyama, K. Yamashita, A. Ishikawa, K. Taima, H. Yoshida, I. Inoue, T. Fujita, S. Yagihashi, and K. Satoh. 2004. Expression of retinoic acid-inducible gene-I in vascular smooth muscle cells stimulated with interferon-γ. Life Sci. 75: 1171-1180.
22. Sakaki, H., T. Imaizumi, T. Matsumiya, A. Kusumi, H. Nakagawa, K. Kubota, N. Nishi, T. Nakamura, M. Hirashima, K. Satoh, and H. Kimura. 2005. Retinoic acid-inducible gene-I is induced by interleukin-1β in cultured human gingival fibroblasts. Oral Microbiol. Immunol. 20: 47-50.
23. Imaizumi, T., S. Aratani, T. Nakajima, M. Carlson, T. Matsumiya, K. Tanji, K. Ookawa, H. Yoshida, S. Tsuchida, T. M. McIntyre, et al. 2002. Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem. Biophys. Res. Commun. 292: 274-279.
24. Imaizumi, T., M. Hatakeyama, K. Yamashita, A. Ishikawa, H. Yoshida, K. Satoh, K. Taima, F. Mori, and K. Wakabayashi. 2005. Double-stranded RNA induces the synthesis of retinoic acid-inducible gene-I in vascular endothelial cells. Endothelium 12: 133-137.
25. Zyad, A., J. Benard, T. Tursz, R. Clarke, and S. Chouaib. 1994. Resistance to TNF-α and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. Cancer Res. 54: 825-831.
26. Aggarwal, S., Y. Takada, A. M. Mhashilkar, K. Sieger, S. Chada, and B. B. Aggarwal. 2004. Melanoma differentiation-associated gene-7/IL-24 gene enhances NF-κB activation and suppresses apoptosis induced by TNF. J. Immunol. 173: 4368-4376.
27. Wei, L., M. R. Sandbulte, P. G. Thomas, R. J. Webby, R. Homayouni, and L. M. Pfeffer. 2006. NFκB negatively regulates interferon-induced gene expression and anti-influenza activity. J. Biol. Chem. 281: 11678-11684.
28. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
29. Malur, A. G., S. Chattopadhyay, R. K. Maitra, and A. K. Banerjee. 2005. Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein. J. Virol. 79: 7877-7882.
30. Tliba, O., S. Tliba, C. Da Huang, R. K. Hoffman, P. DeLong, R. A. Panettieri, Jr., and Y. Amrani. 2003. Tumor necrosis factor α modulates airway smooth muscle function via the autocrine action of interferon β. J. Biol. Chem. 278: 50615-50623.
31. Sasai, M., M. Shingai, K. Funami, M. Yoneyama, T. Fujita, M. Matsumoto, and T. Seya. 2006. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J. Immunol. 177: 8676-8683.
32. Breiman, A., N. Grandvaux, R. Lin, C. Ottone, S. Akira, M. Yoneyama, T. Fujita, J. Hiscott, and E. F. Meurs. 2005. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKε. J. Virol. 79: 3969-3978.
33. Fensterl, V., D. Grotheer, I. Berk, S. Schlemminger, A. Vallbracht, and A. Dotzauer. 2005. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of β interferon. J. Virol. 79: 10968-10977.
34. Foy, E., K. Li, R. Sumpter, Jr., Y. M. Loo, C. L. Johnson, C. Wang, P. M. Fish, M. Yoneyama, T. Fujita, S. M. Lemon, and M. Gale, Jr. 2005. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 102: 2986-2991.
35. Hiscott, J., R. Lin, P. Nakhaei, and S. Paz. 2006. MasterCARD: a priceless link to innate immunity. Trends Mol. Med. 12: 53-56.
36. Seth, R. B., L. Sun, and Z. J. Chen. 2006. Antiviral innate immunity pathways. Cell Res. 16: 141-147.
37. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
38. Kang, D. C., R. V. Gopalkrishnan, Q. Wu, E. Jankowsky, A. M. Pyle, and P. B. Fisher. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA 99: 637-642.
39. Pennica, D., J. S. Hayflick, T. S. Bringman, M. A. Palladino, and D. V. Goeddel. 1985. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82: 6060-6064.
40. Ruuls, S. R., and J. D. Sedgwick. 1999. Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models. Am. J. Hum. Genet. 65: 294-301.
41. Laster, S. M., J. G. Wood, and L. R. Gooding. 1988. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141: 2629-2634.
42. Simon, A., J. Fah, O. Haller, and P. Staeheli. 1991. Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J. Virol. 65: 968-971.
43. Jacobsen, H., J. Mestan, S. Mittnacht, and C. W. Dieffenbach. 1989. Beta interferon subtype 1 induction by tumor necrosis factor. Mol. Cell. Biol. 9: 3037-3042.
44. Wong, L. H., H. Sim, M. Chatterjee-Kishore, I. Hatzinisiriou, R. J. Devenish, G. Stark, and S. J. Ralph. 2002. Isolation and characterization of a human STAT1 gene regulatory element: inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J. Biol. Chem. 277: 19408-19417.
45. Allen, G., and K. H. Fantes. 1980. A family of structural genes for human lymphoblastoid (leukocyte-type) interferon. Nature 287: 408-411.
46. Henco, K., J. Brosius, A. Fujisawa, J. I. Fujisawa, J. R. Haynes, J. Hochstadt, T. Kovacic, M. Pasek, A. Schambock, J. Schmid, et al. 1985. Structural relationship of human interferon α genes and pseudogenes. J. Mol. Biol. 185: 227-260.
47. Derynck, R., J. Content, E. DeClercq, G. Volckaert, J. Tavernier, R. Devos, and W. Fiers. 1980. Isolation and structure of a human fibroblast interferon gene. Nature 285: 542-547.
48. LaFleur, D. W., B. Nardelli, T. Tsareva, D. Mather, P. Feng, M. Semenuk, K. Taylor, M. Buergin, D. Chinchilla, V. Roshke, et al. 2001. Interferon-κ, a novel type I interferon expressed in human keratinocytes. J. Biol. Chem. 276: 39765-39771.